Search for: "Daubert v. Merrell Dow Pharmaceuticals, Inc."
Results 161 - 180
of 202
Sorted by Relevance
|
Sort by Date
22 Jan 2014, 7:37 pm
Merrell Dow Pharmaceuticals, Inc. [read post]
21 Jun 2011, 5:00 am
Merrell Dow Pharmaceuticals, Inc., 509 U.S. 579 (1993), applies to class certifications. [read post]
18 Sep 2019, 10:02 am
Merrell Dow Pharmaceuticals, Inc., 509 U.S. 579, 113 S. [read post]
5 Nov 2007, 12:58 pm
Merrell Dow Pharmaceuticals, Inc., 43 F.3d 1311, 1320 (9th Cir. 1995); DeLuca v. [read post]
14 May 2015, 2:15 pm
Merrell Dow Pharmaceuticals and its progeny, permits a district court to require epidemiological evidence as a precondition for admissibility of a qualified expert's opinion that a toxic substance is capable of causing a particular disease. [read post]
5 Jan 2022, 4:33 am
Merrell Dow Pharmaceuticals, Inc., 509 U.S. 579, 113 S.Ct. 2786, 125 L.Ed.2d 469 (1993).Where does the universe of disability terminate? [read post]
15 Dec 2009, 1:56 pm
Merrell Dow Pharmaceuticals, Inc., 509 U.S. 579, 113 S.Ct. 2786, 125 L.Ed.2d 469 (1993)]). [read post]
1 Apr 2011, 3:00 am
Merrell Dow Pharmaceuticals, Inc., 52 Baylor L. [read post]
14 Aug 2011, 9:11 am
Merrell Dow Pharms., Inc., 509 U.S. 579 (1993). [read post]
13 Sep 2019, 6:00 am
[vi]And then-Justice Rehnquist might have joined the majority in Washington v. [read post]
23 Jan 2014, 9:37 am
Merrell Dow Pharmaceuticals, Inc. [read post]
30 Oct 2013, 10:57 am
Merrell Dow Pharmaceuticals, Inc., 509 U.S. 579, 599 (1993) (Rehnquist, C.J., concurring in part and dissenting in part) (“the various briefs filed in this case … deal with definitions of scientific knowledge, scientific method, scientific validity, and peer review—in short, matters far afield from the expertise of judges”); Marconi Wireless Telegraph Co. [read post]
28 Oct 2013, 7:19 pm
Merrell Dow Pharmaceuticals, Inc. [read post]
10 Sep 2014, 9:00 am
Merrell Dow Pharmaceuticals regarding important expert testimony requires the appellate court to order a new trial, regardless of whether there was actually any substantive error in the expert testimony heard or not heard by the jury. [read post]
20 Apr 2017, 8:23 am
Merrell Dow Pharmaceuticals, Inc., 509 U.S. 579(1993). [read post]
10 Jun 2012, 1:09 pm
Merrell Dow Pharms., Inc., 874 F.2d 307, 311 (5th Cir. 1989) (noting that “[o]ne difficulty with epidemiologic studies is that often several factors can cause the same disease. [read post]
31 Oct 2018, 10:04 am
In some instances, especially in studies pharmaceutical adverse outcomes, there is the danger that the hypothesized outcome is also a feature of the underlying disease being treated. [read post]
6 May 2010, 4:12 pm
Metabolife International, Inc., 401 F.3d 1233, 1247 (11th Cir. 2005); Goebel v. [read post]
14 May 2012, 8:24 am
Perrier Group of America Inc., 986 F. [read post]
31 Jan 2014, 7:11 am
Merrell Dow Pharmaceuticals, Inc. [read post]